While drug shortages have been a challenge in the U.S. for years, the impact of the pandemic on the entire healthcare supply chain was unprecedented as were resulting effects on patients and care givers.
Fresenius Kabi USA sponsored a Becker’s Hospital Review webinar where healthcare leaders discussed how stakeholders can prepare for future disruptions by building more capacity, redundancy and resiliency – and creating the conditions for these necessary capabilities.
- Loressa Cole, DNP, RN, CEO, American Nurses Association
- Valerie Jensen, associate director, CDER drug shortage staff, FDA
- Jonathan Kimball, vice president, trade, international affairs and strategic initiatives, Association for Accessible Medicines
- Scott Meacham, president, pharmaceuticals, Fresenius Kabi USA